Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:2626-2632

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malmberg, K.
Right arrow Articles by Rydén, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malmberg, K.
Right arrow Articles by Rydén, L.
Related Collections
Right arrow Other Treatment
Right arrow Acute myocardial infarction

(Circulation. 1999;99:2626-2632.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction

Long-Term Results From the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study

Klas Malmberg, MD, PhD; Anna Norhammar, MD; Hans Wedel, PhD; Lars Rydén, MD, PhD

From the Department of Cardiology, Karolinska Hospital (K.M., A.N., L.R.), Stockholm, and Nordic School for Public Health (H.W.), Göteborg, Sweden.

Correspondence to Lars Rydén, MD, Department of Cardiology, Karolinska Hospital, S-171 76 Stockholm, Sweden.

Background—The Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study addressed prognostic factors and the effects of concomitant treatment and glycometabolic control in diabetic patients with myocardial infarction (AMI).

Methods and Results—Of 620 diabetic patients with AMI, 306 were randomly assigned to a >=24-hour insulin-glucose infusion followed by multidose subcutaneous insulin. Three hundred fourteen patients were randomized as controls, receiving routine antidiabetic therapy. Thrombolysis and ß-blockers were administered when possible. Univariate and multivariate statistical analyses were applied to study predictors of long-term mortality. During an average follow-up of 3.4 years (range, 1.6 to 5.6 years), 102 patients (33%) in the intensive insulin group and 138 (44%) in the control group died (P=0.011). Old age, previous heart failure, diabetes duration, admission blood glucose, and admission Hb AIc were independent predictors of mortality in the total cohort, whereas previous AMI, hypertension, smoking, or female sex did not add independent predictive value. Metabolic control, mirrored by blood glucose and Hb AIc, improved significantly more in patients on intensive insulin treatment than in the control group. ß-Blockers improved survival in control subjects, whereas thrombolysis was most efficient in the intensive insulin group.

Conclusions—Mortality in diabetic patients with AMI is predicted by age, previous heart failure, and severity of the glycometabolic state at admission but not by conventional risk factors or sex. Intensive insulin treatment reduced long-term mortality despite high admission blood glucose and Hb AIc.


Key Words: myocardial infarction • diabetes mellitus • mortality • morbidity • glucose • insulin




This article has been cited by other articles:


Home page
CirculationHome page
P. Deedwania, M. Kosiborod, E. Barrett, A. Ceriello, W. Isley, T. Mazzone, and P. Raskin
Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism
Circulation, March 25, 2008; 117(12): 1610 - 1619.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. W. Nesto and R. M. Lago
Glucose: A Biomarker in Acute Myocardial Infarction Ready for Prime Time?
Circulation, February 26, 2008; 117(8): 990 - 992.
[Full Text] [PDF]


Home page
CirculationHome page
M. Kosiborod, S. E. Inzucchi, H. M. Krumholz, L. Xiao, P. G. Jones, S. Fiske, F. A. Masoudi, S. P. Marso, and J. A. Spertus
Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk
Circulation, February 26, 2008; 117(8): 1018 - 1027.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. G. Mellbin, K. Malmberg, A. Norhammar, H. Wedel, L. Ryden, and for the DIGAMI 2 Investigators
The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial
Eur. Heart J., January 2, 2008; 29(2): 166 - 176.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Fernandez, C. Triplitt, E. Wajcberg, A. A. Sriwijilkamol, N. Musi, K. Cusi, R. DeFronzo, and E. Cersosimo
Addition of Pioglitazone and Ramipril to Intensive Insulin Therapy in Type 2 Diabetic Patients Improves Vascular Dysfunction by Different Mechanisms
Diabetes Care, January 1, 2008; 31(1): 121 - 127.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. A. Ballweg, G. Wernovsky, R. F. Ittenbach, J. Bernbaum, M. Gerdes, P. R. Gallagher, T. E. Dominguez, E. Zackai, R. R. Clancy, S. C. Nicolson, et al.
Hyperglycemia After Infant Cardiac Surgery Does Not Adversely Impact Neurodevelopmental Outcome
Ann. Thorac. Surg., December 1, 2007; 84(6): 2052 - 2058.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A. Norhammar, J. Lindback, L. Ryden, L. Wallentin, U. Stenestrand, and on behalf of the Register of Information and Knowl
Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission
Heart, December 1, 2007; 93(12): 1577 - 1583.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C Weston, L Walker, J Birkhead, and National Audit of Myocardial Infarction Project, N
Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome
Heart, December 1, 2007; 93(12): 1542 - 1546.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
K. Asadollahi, N. Beeching, and G. Gill
Hyperglycaemia and mortality
J R Soc Med, November 1, 2007; 100(11): 503 - 507.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. W. Zarich and R. W. Nesto
Implications and Treatment of Acute Hyperglycemia in the Setting of Acute Myocardial Infarction
Circulation, May 8, 2007; 115(18): e436 - e439.
[Full Text] [PDF]


Home page
Eur Heart JHome page
K. K. Ray, C. P. Cannon, D. A. Morrow, A. J. Kirtane, J. Buros, N. Rifai, C. H. McCabe, C. M. Gibson, and E. Braunwald
Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18
Eur. Heart J., April 2, 2007; (2007) ehm010v1.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. E. Inzucchi
Management of Hyperglycemia in the Hospital Setting
N. Engl. J. Med., November 2, 2006; 355(18): 1903 - 1911.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D.-Y. Hu, C.-Y. Pan, J.-M. Yu, and for the China Heart Survey Group
The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey
Eur. Heart J., November 1, 2006; 27(21): 2573 - 2579.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Ishihara, I. Inoue, T. Kawagoe, Y. Shimatani, S. Kurisu, T. Hata, Y. Nakama, Y. Kijima, and E. Kagawa
Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?
Eur. Heart J., October 2, 2006; 27(20): 2413 - 2419.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. W. A. Smit and J. A. Romijn
Acute insulin resistance in myocardial ischemia: causes and consequences.
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 215 - 219.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
A. Barsheshet, M. Garty, E. Grossman, A. Sandach, B. S. Lewis, S. Gottlieb, A. Shotan, S. Behar, A. Caspi, R. Schwartz, et al.
Admission Blood Glucose Level and Mortality Among Hospitalized Nondiabetic Patients With Heart Failure.
Arch Intern Med, August 14, 2006; 166(15): 1613 - 1619.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
The ACE/ADA Task Force on Inpatient Diabetes
American College of Endocrinology and American Diabetes Association Consensus Statement on Inpatient Diabetes and Glycemic Control: A call to action
Diabetes Care, August 1, 2006; 29(8): 1955 - 1962.
[Full Text] [PDF]


Home page
HeartHome page
Z Kadri, N Danchin, L Vaur, Y Cottin, P Gueret, M Zeller, J-M Lablanche, D Blanchard, G Hanania, N Genes, et al.
Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study
Heart, July 1, 2006; 92(7): 910 - 915.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Arimura, M. Li, V. Batuman, W.F. Clark, A.K. Stewart, G.A. Rock, M. Sternbach, D.M. Sutton, B.J. Barrett, A.P. Heidenheim, et al.
Cast Nephropathy in Myeloma--Does PACAP38, a New Member of the Vasoactive Intestinal Peptide Family, Open a Therapeutic Window?: Potential Protective Action of Pituitary Adenylate Cyclase-Activiating Polypeptide (PACAP38) on In Vitro and In Vivo Models of Myeloma Kidney Injury. Blood 107: 661-668, 2006
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 911 - 919.
[Full Text] [PDF]


Home page
QJMHome page
J.R. Timmer, J.P. Ottervanger, H.J.G. Bilo, J.H.E. Dambrink, K. Miedema, J.C.A. Hoorntje, and F. Zijlstra
Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes
QJM, April 1, 2006; 99(4): 237 - 243.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Ishii, S. Ichimiya, M. Kanashiro, T. Amano, T. Matsubara, and T. Murohara
Effects of Intravenous Nicorandil Before Reperfusion for Acute Myocardial Infarction in Patients With Stress Hyperglycemia
Diabetes Care, February 1, 2006; 29(2): 202 - 206.
[Abstract] [Full Text] [PDF]


Home page
The Diabetes EducatorHome page
E. D. Davis, K. Harwood, L. Midgett, M. Mabrey, and L. F. Lien
Implementation of a New Intravenous Insulin Method on Intermediate-Care Units in Hospitalized Patients
The Diabetes Educator, November 1, 2005; 31(6): 818 - 823.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. X. Freire, L. Bridges, G. E. Umpierrez, D. Kuhl, and A. E. Kitabchi
Admission Hyperglycemia and Other Risk Factors as Predictors of Hospital Mortality in a Medical ICU Population
Chest, November 1, 2005; 128(5): 3109 - 3116.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Ramachandran, S. Chamukuttan, S. Immaneni, R. M. Shanmugam, N. Vishnu, V. Viswanathan, and T. Jaakko
High Incidence of Glucose Intolerance in Asian-Indian Subjects With Acute Coronary Syndrome
Diabetes Care, October 1, 2005; 28(10): 2492 - 2496.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. J. Meier, S. Deifuss, A. Klamann, V. Launhardt, W. H. Schmiegel, and M. A. Nauck
Plasma Glucose at Hospital Admission and Previous Metabolic Control Determine Myocardial Infarct Size and Survival in Patients With and Without Type 2 Diabetes: The Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA)
Diabetes Care, October 1, 2005; 28(10): 2551 - 2553.
[Full Text] [PDF]


Home page
Eur Heart JHome page
R.E. Anderson, K. Klerdal, T. Ivert, N. Hammar, G. Barr, and A. Owall
Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?
Eur. Heart J., August 1, 2005; 26(15): 1513 - 1518.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. Veiraiah
Hyperglycemia, Lipoprotein Glycation, and Vascular Disease
Angiology, July 1, 2005; 56(4): 431 - 438.
[Abstract] [PDF]


Home page
Eur Heart JHome page
A. Abbate and G. G.L. Biondi-Zoccai
The difficult task of glycaemic control in diabetics with acute coronary syndromes: finding the way to normoglycaemia avoiding both hyper- and hypoglycaemia
Eur. Heart J., July 1, 2005; 26(13): 1245 - 1248.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Zeller, P. G. Steg, J. Ravisy, Y. Laurent, L. Janin-Manificat, I. L'Huillier, J.-C. Beer, A. Oudot, G. Rioufol, H. Makki, et al.
Prevalence and Impact of Metabolic Syndrome on Hospital Outcomes in Acute Myocardial Infarction
Arch Intern Med, May 23, 2005; 165(10): 1192 - 1198.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
Z. Rusavy, I. A. Macdonald, V. Sramek, S. Lacigova, P. Tesinsky, and I. Novak
Glycemia Influences on Glucose Metabolism in Sepsis During Hyperinsulinemic Clamp
JPEN J Parenter Enteral Nutr, May 1, 2005; 29(3): 171 - 175.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
I. B. Hirsch, R. M. Bergenstal, C. G. Parkin, E. Wright Jr., and J. B. Buse
A Real-World Approach to Insulin Therapy in Primary Care Practice
Clin. Diabetes, April 1, 2005; 23(2): 78 - 86.
[Full Text] [PDF]


Home page
Diabetes CareHome page
M. Bryer-Ash and A. J. Garber
Point: Inpatient Glucose Management: The emperor finally has clothes
Diabetes Care, April 1, 2005; 28(4): 973 - 975.
[Full Text] [PDF]


Home page
Diabetes CareHome page
S. E. Inzucchi and J. Rosenstock
Counterpoint: Inpatient Glucose Management: A premature call to arms?
Diabetes Care, April 1, 2005; 28(4): 976 - 979.
[Full Text] [PDF]


Home page
JAMAHome page
J. D. Flaherty and C. J. Davidson
Diabetes and Coronary Revascularization
JAMA, March 23, 2005; 293(12): 1501 - 1508.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Ceriello
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction
Eur. Heart J., February 2, 2005; 26(4): 328 - 331.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Endorsed by the European Society of Intensive Care, Authors/Task Force Members, M. S. Nieminen, M. Bohm, M. R. Cowie, H. Drexler, G. S. Filippatos, G. Jondeau, Y. Hasin, J. Lopez-Sendon, et al.
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
Eur. Heart J., February 2, 2005; 26(4): 384 - 416.
[Full Text] [PDF]


Home page
J Intensive Care MedHome page
O. Akca and R. Lenhardt
Letter to the Editors: Isn't It the Time to Consider Blood Glucose Concentration as Part of the Severity Assessment of Critically Ill Patients?
J Intensive Care Med, January 1, 2005; 20(1): 52 - 53.
[PDF]


Home page
DiabetesHome page
A. Ceriello
Postprandial Hyperglycemia and Diabetes Complications: Is It Time to Treat?
Diabetes, January 1, 2005; 54(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. M. Choi, K. W. Lee, S. G. Kim, N. H. Kim, C. G. Park, H. S. Seo, D. J. Oh, D. S. Choi, and S. H. Baik
Inflammation, Insulin Resistance, and Glucose Intolerance in Acute Myocardial Infarction Patients without a Previous Diagnosis of Diabetes Mellitus
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 175 - 180.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Ceriello
Insulin, Glycemic Control, and C-Reactive Protein During Myocardial Infarction
Diabetes Care, December 1, 2004; 27(12): 3017 - 3018.
[Full Text] [PDF]


Home page
DiabetesHome page
S.-B. Catrina, K. Okamoto, T. Pereira, K. Brismar, and L. Poellinger
Hyperglycemia Regulates Hypoxia-Inducible Factor-1{alpha} Protein Stability and Function
Diabetes, December 1, 2004; 53(12): 3226 - 3232.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Bartnik, L. Ryden, R. Ferrari, K. Malmberg, K. Pyorala, M. Simoons, E. Standl, J. Soler-Soler, J. Ohrvik, and on behalf of the Euro Heart Survey Investigators
The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart
Eur. Heart J., November 1, 2004; 25(21): 1880 - 1890.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Kragelund, O. Snorgaard, L. Kober, B. Bengtsson, M. Ottesen, S. Hojberg, C. Olesen, J.-J. Kjaergaard, J. Carlsen, C. Torp-Petersen, et al.
Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients
Eur. Heart J., November 1, 2004; 25(21): 1891 - 1897.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
G. Carvalho and T. Schricker
An ounce of prevention worth a pound of cure
Can J Anesth, November 1, 2004; 51(9): 948 - 949.
[Full Text] [PDF]


Home page
CirculationHome page
D. Aguilar, S. D. Solomon, L. Kober, J.-L. Rouleau, H. Skali, J. J.V. McMurray, G. S. Francis, M. Henis, C. M. O'Connor, R. Diaz, et al.
Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial
Circulation, September 21, 2004; 110(12): 1572 - 1578.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. B. Coursin and R. C. Prielipp
The New Anesthesia Diet Plan: Keeping Perioperative Carbs in Check
Anesth. Analg., August 1, 2004; 99(2): 316 - 318.
[Full Text] [PDF]


Home page
CirculationHome page
A. Kouroedov, M. Eto, H. Joch, M. Volpe, T. F. Luscher, and F. Cosentino
Selective Inhibition of Protein Kinase C{beta}2 Prevents Acute Effects of High Glucose on Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells
Circulation, July 6, 2004; 110(1): 91 - 96.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Aljada, H. Ghanim, P. Mohanty, T. Syed, A. Bandyopadhyay, and P. Dandona
Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. LeRoith
Editorial: A Blast from the Past--Insulin Does It Again!
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3103 - 3104.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
K. S Lewis, S. L Kane-Gill, M. B. Bobek, and J. F Dasta
Intensive Insulin Therapy for Critically Ill Patients
Ann. Pharmacother., July 1, 2004; 38(7): 1243 - 1251.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. R Timmer, J. P. Ottervanger, K. Thomas, J. C.A Hoorntje, M.-J. de Boer, H. Suryapranata, F. Zijlstra, and on behalf of the Zwolle myocardial infarction stud
Long-term, cause-specific mortality after myocardial infarction in diabetes
Eur. Heart J., June 1, 2004; 25(11): 926 - 931.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
E. Barrett-Connor, E.-G. V. Giardina, A. K. Gitt, U. Gudat, H. O. Steinberg, and D. Tschoepe
Women and Heart Disease: The Role of Diabetes and Hyperglycemia
Arch Intern Med, May 10, 2004; 164(9): 934 - 942.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
I. Stranders, M. Diamant, R. E. van Gelder, H. J. Spruijt, J. W. R. Twisk, R. J. Heine, and F. C. Visser
Admission Blood Glucose Level as Risk Indicator of Death After Myocardial Infarction in Patients With and Without Diabetes Mellitus
Arch Intern Med, May 10, 2004; 164(9): 982 - 988.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
K. B. Campbell and S. S. Braithwaite
Hospital Management of Hyperglycemia
Clin. Diabetes, April 1, 2004; 22(2): 81 - 88.
[Full Text] [PDF]


Home page
Diabetes Spectr.Home page
G. Spollett
Glucose Control in a Hospitalized Person With Diabetes
Diabetes Spectr, April 1, 2004; 17(2): 112 - 114.
[Full Text] [PDF]


Home page
J Clin PharmacolHome page
S. Mudaliar
Intense Management of Diabetes Mellitus: Role of Glucose Control and Antiplatelet Agents
J. Clin. Pharmacol., April 1, 2004; 44(4): 414 - 422.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H Laine, J Sundell, P Nuutila, O T Raitakari, M Luotolahti, T Ronnemaa, T Elomaa, P Koskinen, and J Knuuti
Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes
Heart, March 1, 2004;